Literature DB >> 22584378

Inhibitory effect of Ferula asafoetida L. (Umbelliferae) on Blastocystis sp. subtype 3 growth in vitro.

Hala K El Deeb1, Faisal M Al Khadrawy, Ayman K Abd El-Hameid.   

Abstract

Asafoetida is an oleo-gum-resin obtained from many Ferula species and frequently used in traditional medicine. The current study aimed to evaluate the activity of asafoetida against the in vitro growth of Blastocystis sp. Asafoetida as powder-form (Ap) and oil-form (Ao) extracts at concentrations of 2, 4, 8, 16, and 20 mg/ml and 5, 10, 25, 40, and 50 mg/ml, respectively were incubated with isolates of Blastocystis sp. subtype 3 for 24, 72, and 144 h and compared to the reference antiprotozoan drug metronidazole at concentrations of 10, 100, and 500 μg/ml. Asafoetida either as Ap or Ao decreased counts and viability of all tested isolates of Blastocystis sp. subtype 3 which was confirmed by microscopy. The degree of the inhibitory effect was dependent on the concentration, form, as well as the time of incubation with asafoetida extracts. The lowest concentrations of Ap and Ao that caused complete (100 %) inhibition of Blastocystis growth and highest (100 %) percentage inhibition of multiplication was 16 and 40 mg/ml, respectively; mean counts at these concentrations either did not differ or decreased significantly when compared to metronidazole control (p < 0.05). Also, the parasites did not resume growth after re-cultivation in asafoetida-free medium when examined further after 48, 72, and 144 h of cultivation. These findings demonstrate the potential of phytomedicine asafoetida as a potent natural alternative for treatment of Blastocystis sp.infection.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22584378     DOI: 10.1007/s00436-012-2955-1

Source DB:  PubMed          Journal:  Parasitol Res        ISSN: 0932-0113            Impact factor:   2.289


  52 in total

1.  Proteaese activity of Blastocystis hominis subtype3 in symptomatic and asymptomatic patients.

Authors:  Dina Marie Abdel-Hameed; Omayma Mohamed Hassanin
Journal:  Parasitol Res       Date:  2011-01-29       Impact factor: 2.289

2.  Chemotherapy of leishmaniasis Part VI: synthesis and bioevaluation of some novel terpenyl S,N- and N,N-acetals.

Authors:  S N Suryawanshi; Susmita Pandey; B A Bhatt; Suman Gupta
Journal:  Eur J Med Chem       Date:  2006-12-18       Impact factor: 6.514

3.  Asafoetida inhibits early events of carcinogenesis: a chemopreventive study.

Authors:  M Saleem; A Alam; S Sultana
Journal:  Life Sci       Date:  2001-03-09       Impact factor: 5.037

4.  Metronidazole and albendazole susceptibility of 11 clinical isolates of Giardia duodenalis from France.

Authors:  V Lemée; I Zaharia; G Nevez; M Rabodonirina; P Brasseur; J J Ballet; L Favennec
Journal:  J Antimicrob Chemother       Date:  2000-11       Impact factor: 5.790

5.  Irritable bowel syndrome: in search of an etiology: role of Blastocystis hominis.

Authors:  Javed Yakoob; Wasim Jafri; Nadim Jafri; Rustam Khan; Muhammad Islam; M Asim Beg; Viqar Zaman
Journal:  Am J Trop Med Hyg       Date:  2004-04       Impact factor: 2.345

6.  The in vitro effect of Assafoetida on Trichomonas vaginalis.

Authors:  Nashwa I Ramadan; Faisal M Al Khadrawy
Journal:  J Egypt Soc Parasitol       Date:  2003-08

7.  Pathophysiological variability of different genotypes of human Blastocystis hominis Egyptian isolates in experimentally infected rats.

Authors:  Eman M Hussein; Abdalla M Hussein; Mohamed M Eida; Maha M Atwa
Journal:  Parasitol Res       Date:  2008-01-11       Impact factor: 2.289

8.  Chemomodulatory influence of Ferula asafoetida on mammary epithelial differentiation, hepatic drug metabolizing enzymes, antioxidant profiles and N-methyl-N-nitrosourea-induced mammary carcinogenesis in rats.

Authors:  G U Mallikarjuna; S Dhanalakshmi; S Raisuddin; A Ramesha Rao
Journal:  Breast Cancer Res Treat       Date:  2003-09       Impact factor: 4.872

9.  Evidence of waterborne transmission of Blastocystis hominis.

Authors:  Saovanee Leelayoova; Ram Rangsin; Paanjit Taamasri; Tawee Naaglor; Umaporn Thathaisong; Mathirut Mungthin
Journal:  Am J Trop Med Hyg       Date:  2004-06       Impact factor: 2.345

10.  Structure-based virtual screening for the discovery of natural inhibitors for human rhinovirus coat protein.

Authors:  Judith M Rollinger; Theodora M Steindl; Daniela Schuster; Johannes Kirchmair; Kathrin Anrain; Ernst P Ellmerer; Thierry Langer; Hermann Stuppner; Peter Wutzler; Michaela Schmidtke
Journal:  J Med Chem       Date:  2008-02-05       Impact factor: 7.446

View more
  6 in total

1.  Role of the potassium channels in vasorelaxant effect of asafoetida essential oil.

Authors:  Hassan Esmaeili; Mansour Esmailidehaj; Somayeh Entezari Zarch; Hossein Azizian
Journal:  Avicenna J Phytomed       Date:  2020 Jul-Aug

Review 2.  Blastocystis: how do specific diets and human gut microbiota affect its development and pathogenicity?

Authors:  M Lepczyńska; J Białkowska; E Dzika; K Piskorz-Ogórek; J Korycińska
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-03-22       Impact factor: 3.267

3.  The influence of probiotic bacteria and human gut microorganisms causing opportunistic infections on Blastocystis ST3.

Authors:  M Lepczyńska; E Dzika
Journal:  Gut Pathog       Date:  2019-02-14       Impact factor: 4.181

4.  In vitro susceptibility of human Blastocystis subtypes to simeprevir.

Authors:  Shereen F Mossallam; Salwa A T El-Mansoury; Mona M Tolba; Asmaa A Kohla; Safaa I Khedr
Journal:  Saudi J Biol Sci       Date:  2021-02-02       Impact factor: 4.219

Review 5.  Biological activities and medicinal properties of Asafoetida: A review.

Authors:  Augustine Amalraj; Sreeraj Gopi
Journal:  J Tradit Complement Med       Date:  2016-12-20

6.  The effect of asafoetida essential oil on myocardial ischemic-reperfusion injury in isolated rat hearts.

Authors:  Hassan Esmaeili; Zahra Hafezimoghadam; Mansour Esmailidehaj; Mohammad Ebrahim Rezvani; Zeynab Hafizibarjin
Journal:  Avicenna J Phytomed       Date:  2018 Jul-Aug
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.